Weight | 370.314 g/mol |
---|---|
Formula | C15H18N2O9 |
Hydrogen Acceptors | 10 |
Hydrogen Donors | 1 |
Aromatic Rings | 1 |
Rotatable Bonds | 5 |
Uridine triacetate (4105-38-8)
2',3',5'-tri-O-acetyluridine · triacetyluridine
"What do you need help with?"
LabBot
- Sigma-Aldrich - Search for Uridine triacetate
- Fisher Scientific - Search for Uridine triacetate
- TCI - Search for Uridine triacetate
- Functionalisation including fluorination of caffeine, guanosine tetraacetate, and uridine triacetate using electrochemical oxidation (Tetrahedron Letters, 1994)
- Triacetyluridine (TAU) Decreases Depressive Symptoms and Increases Brain pH in Bipolar Patients (Experimental and Clinical Psychopharmacology, 2008)
- Neuroprotective effects of oral administration of triacetyluridine against MPTP neurotoxicity. (Neuromolecular Medicine, 2004)
- 5-Fluorouracil dose escalation enabled with PN401 (triacetyluridine): toxicity reduction and increased antitumor activity in mice (Cancer Chemotherapy and Pharmacology, 2006)
- Use of uridine triacetate for the management of fluorouracil overdose (American Journal of Health-system Pharmacy, 2011)
- Enhanced Uridine Bioavailability Following Administration of a Triacetyluridine-Rich Nutritional Supplement (PLOS ONE, 2011)
-
Including Acute Oral Tox, Skin Sensitization, Eye Irritation, Aquatic Tox, & more. - 2',3',5'-tri-O-acetyluridine
- triacetyluridine
-
SMILESCC(=O)OCC1C(C(C(O1)N2C=CC(=O)NC2=O)OC(=O)C)OC(=O)C
-
InChIKeyAUFUWRKPQLGTGF-UHFFFAOYSA-N
- Pubchem - Uridine triacetate
- Wikipedia - uridine triacetate
Uridine triacetate (INN), formerly known as vistonuridine, is an orally active tri-acetylated prodrug of uridine used: in the treatment of hereditary orotic aciduria (brand name Xuriden ZOOR--den); to treat patients following an overdose of chemotherapy drugs 5-fluorouracil (5-FU) or capecitabine regardless of the presence of symptoms, or who exhibit early-onset, severe or life-threatening toxicity affecting the cardiac or central nervous system, and/or early-onset, unusually severe adverse reactions (e.g., gastrointestinal toxicity and/or neutropenia) within 96 hours following the end of fluorouracil or capecitabine administration (brand name Vistogard). Uridine triacetate was developed, manufactured and distributed by Wellstat Therapeutics and it is marketed in USA by BTG. Also, It was granted breakthrough therapy designation by FDA in 2015.
Suppliers
Most-cited Publications
Safety
Trends
Alternate Names
External Links
Similar Compounds
alpha-D-Glucose pentaacetate
(604-68-2)
3 alternate names
3 suppliers
ETHOFUMESATE
(26225-79-6)
3 alternate names
1 safety hazard
3 suppliers
n-acetyl-a-aspartylglutamic acid
(3106-85-2)
3 alternate names
3 suppliers
doxifluridine
(3094-09-5)
3 alternate names
3 suppliers
Isospaglumic acid
(3106-85-2)
3 alternate names
3 suppliers
Tetraacetylethylenediamine
(10543-57-4)
3 alternate names
3 suppliers
Melengestro acetate
(425-51-4, 595-33-5)
3 alternate names
3 suppliers
HELENALIN
(6754-13-8)
3 alternate names
3 suppliers
Phenylacetylglutamine
(28047-15-6)
3 alternate names
3 suppliers
Acetyl triethyl citrate
(77-89-4)
3 alternate names
3 suppliers
ACETYL TRIBUTYL CITRATE
(77-90-7)
3 alternate names
3 suppliers
3-Phenoxypropylene di(acetate)
(75-20-7, 7250-71-7)
3 alternate names
2 safety hazards
3 suppliers
8-Hydroxyguanosine
(3868-31-3)
3 alternate names
3 suppliers
Pentaerythritol triacrylate
(3524-68-3)
3 alternate names
5 safety hazards
3 suppliers
N,N'-Diacetylbenzidine
(613-35-4)
3 alternate names
4 safety hazards
3 suppliers
6846-50-0
(6846-50-0)
3 alternate names
3 suppliers
COUMAFURYL
(117-52-2)
3 alternate names
2 safety hazards
3 suppliers
Peramivir
(1041434-82-5, 229614-55-5, 229614-56-6, 330600-85-6)
3 alternate names
3 suppliers
2-(Benzoylamino)benzoic acid
(579-93-1)
3 alternate names
3 suppliers
1,2,3,4-BUTANETETRACARBOXYLIC ACID
(1703-58-8)
3 alternate names
3 suppliers
Sulcotrione
(99105-77-8, 114680-61-4)
3 alternate names
3 safety hazards
3 suppliers
Diethofencarb
(87130-20-9)
3 alternate names
3 suppliers
Phthalyl-DL-glutamic Acid
(2301-52-2, 6349-98-0)
3 alternate names
3 suppliers
EGTA
(67-42-5)
3 alternate names
3 suppliers
Tetramethrin
(66525-27-7, 7696-12-0)
3 alternate names
2 safety hazards
3 suppliers
d-Tetramethrin
(1166-46-7, 52556-74-8, 7696-12-0, 5284-41-3)
3 alternate names
3 suppliers
triacetin
(102-76-1)
3 alternate names
3 suppliers
5-BROMO-2'-DEOXYURIDINE
(59-14-3)
3 alternate names
3 suppliers
chlormadinone acetate
(302-22-7)
3 alternate names
3 suppliers
Annatto
(626-76-6, 1393-63-1)
3 alternate names
3 suppliers
Forchlorfenuron
(68157-60-8)
3 alternate names
1 safety hazard
3 suppliers
Bromoouridine
(59-14-3)
3 alternate names
3 suppliers
Tonalid
(1506-02-1, 21145-77-7)
3 alternate names
3 suppliers
Oseltamivir phosphate
(204255-11-8)
3 alternate names
3 suppliers
Pirinixic acid
(50892-23-4)
3 alternate names
3 suppliers
TRIMETHYLOLPROPANE TRIACRYLATE
(15625-89-5)
3 alternate names
2 safety hazards
3 suppliers
Pentetic acid
(12111-24-9, 67-43-6)
3 alternate names
3 suppliers
OXADIAZON
(19666-30-9)
3 alternate names
3 safety hazards
3 suppliers
Diacetoxyscirpenol
(2270-40-8, 29638-94-6)
3 alternate names
3 suppliers
Diacetoxyscirpenol
(2270-40-8)
3 alternate names
3 suppliers
Diacetoxyscirpenol
(2270-40-8)
3 alternate names
3 suppliers
4,15-Diacetoxyscirpenol
(2270-40-8)
3 alternate names
3 suppliers
Phenmedipham
(13684-63-4)
3 alternate names
3 safety hazards
3 suppliers
Anguidine
(2270-40-8)
3 alternate names
3 suppliers
CAS Directory